Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Chem ; 60(23): 9860-9873, 2017 12 14.
Article in English | MEDLINE | ID: mdl-29148769

ABSTRACT

Monoacylglycerol lipase (MAGL) is the main enzyme responsible for degradation of the endocannabinoid 2-arachidonoylglycerol (2-AG) in the CNS. MAGL catalyzes the conversion of 2-AG to arachidonic acid (AA), a precursor to the proinflammatory eicosannoids such as prostaglandins. Herein we describe highly efficient MAGL inhibitors, identified through a parallel medicinal chemistry approach that highlighted the improved efficiency of azetidine and piperidine-derived carbamates. The discovery and optimization of 3-substituted azetidine carbamate irreversible inhibitors of MAGL were aided by the generation of inhibitor-bound MAGL crystal structures. Compound 6, a highly efficient and selective MAGL inhibitor against recombinant enzyme and in a cellular context, was tested in vivo and shown to elevate central 2-AG levels at a 10 mg/kg dose.


Subject(s)
Azetidines/pharmacology , Carbamates/pharmacology , Enzyme Inhibitors/pharmacology , Monoacylglycerol Lipases/antagonists & inhibitors , Piperidines/pharmacology , Animals , Azetidines/chemistry , Azetidines/pharmacokinetics , Carbamates/chemistry , Carbamates/pharmacokinetics , Cell Line , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacokinetics , Humans , Mice, Inbred C57BL , Models, Molecular , Monoacylglycerol Lipases/metabolism , Piperidines/chemistry , Piperidines/pharmacokinetics , Recombinant Proteins/metabolism
2.
PLoS One ; 12(9): e0184843, 2017.
Article in English | MEDLINE | ID: mdl-28934246

ABSTRACT

Cyclic GMP-AMP synthase (cGAS) initiates the innate immune system in response to cytosolic dsDNA. After binding and activation from dsDNA, cGAS uses ATP and GTP to synthesize 2', 3' -cGAMP (cGAMP), a cyclic dinucleotide second messenger with mixed 2'-5' and 3'-5' phosphodiester bonds. Inappropriate stimulation of cGAS has been implicated in autoimmune disease such as systemic lupus erythematosus, thus inhibition of cGAS may be of therapeutic benefit in some diseases; however, the size and polarity of the cGAS active site makes it a challenging target for the development of conventional substrate-competitive inhibitors. We report here the development of a high affinity (KD = 200 nM) inhibitor from a low affinity fragment hit with supporting biochemical and structural data showing these molecules bind to the cGAS active site. We also report a new high throughput cGAS fluorescence polarization (FP)-based assay to enable the rapid identification and optimization of cGAS inhibitors. This FP assay uses Cy5-labelled cGAMP in combination with a novel high affinity monoclonal antibody that specifically recognizes cGAMP with no cross reactivity to cAMP, cGMP, ATP, or GTP. Given its role in the innate immune response, cGAS is a promising therapeutic target for autoinflammatory disease. Our results demonstrate its druggability, provide a high affinity tool compound, and establish a high throughput assay for the identification of next generation cGAS inhibitors.


Subject(s)
Enzyme Inhibitors/pharmacology , Nucleotidyltransferases/antagonists & inhibitors , Pyrazoles/pharmacology , Pyrimidines/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/chemical synthesis , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antibodies/metabolism , Drug Discovery , Enzyme Inhibitors/chemical synthesis , Enzyme-Linked Immunosorbent Assay , Fluorescence Polarization , Humans , Mass Spectrometry , Models, Molecular , Molecular Structure , Nucleotides, Cyclic/immunology , Nucleotidyltransferases/metabolism , Protein Binding , Pyrazoles/chemical synthesis , Pyrimidines/chemical synthesis
3.
J Am Chem Soc ; 134(4): 1978-81, 2012 Feb 01.
Article in English | MEDLINE | ID: mdl-22280495

ABSTRACT

The asialoglycoprotein receptor (ASGPR) is a high-capacity galactose-binding receptor expressed on hepatocytes that binds its native substrates with low affinity. More potent ligands are of interest for hepatic delivery of therapeutic agents. We report several classes of galactosyl analogues with varied substitution at the anomeric, C2-, C5-, and C6-positions. Significant increases in binding affinity were noted for several trifluoromethylacetamide derivatives without covalent attachment to the protein. A variety of new ligands were obtained with affinity for ASGPR as good as or better than that of the parent N-acetylgalactosamine, showing that modification on either side of the key C3,C4-diol moiety is well tolerated, consistent with previous models of a shallow binding pocket. The galactosyl pyranose motif therefore offers many opportunities for the attachment of other functional units or payloads while retaining low-micromolar or better affinity for the ASGPR.


Subject(s)
Acetylgalactosamine/chemistry , Asialoglycoprotein Receptor/chemistry , Acetylgalactosamine/analogs & derivatives , Humans , Ligands , Molecular Structure , Stereoisomerism
4.
Nat Struct Mol Biol ; 14(2): 106-13, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17237796

ABSTRACT

Cholesteryl ester transfer protein (CETP) shuttles various lipids between lipoproteins, resulting in the net transfer of cholesteryl esters from atheroprotective, high-density lipoproteins (HDL) to atherogenic, lower-density species. Inhibition of CETP raises HDL cholesterol and may potentially be used to treat cardiovascular disease. Here we describe the structure of CETP at 2.2-A resolution, revealing a 60-A-long tunnel filled with two hydrophobic cholesteryl esters and plugged by an amphiphilic phosphatidylcholine at each end. The two tunnel openings are large enough to allow lipid access, which is aided by a flexible helix and possibly also by a mobile flap. The curvature of the concave surface of CETP matches the radius of curvature of HDL particles, and potential conformational changes may occur to accommodate larger lipoprotein particles. Point mutations blocking the middle of the tunnel abolish lipid-transfer activities, suggesting that neutral lipids pass through this continuous tunnel.


Subject(s)
Cholesterol Ester Transfer Proteins/chemistry , Cholesterol Esters/chemistry , Models, Molecular , Phosphatidylcholines/chemistry , Triglycerides/chemistry , Animals , Binding Sites , CHO Cells , Cholesterol Ester Transfer Proteins/genetics , Cricetinae , Cricetulus , Crystallography, X-Ray , Humans , Hydrophobic and Hydrophilic Interactions , Ligands , Point Mutation , Protein Binding , Protein Conformation
SELECTION OF CITATIONS
SEARCH DETAIL
...